Back
Hanesbrands 10K Form
Buy
56
HBI
Hanesbrands
Last Price:
8.50
Seasonality Move:
6.88%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-09 | 10Q | HBI/Hanesbrands Quarterly |
| 2023-08-10 | 10Q | HBI/Hanesbrands Quarterly |
| 2023-05-03 | 10Q | HBI/Hanesbrands Quarterly |
| 2022-11-09 | 10Q | HBI/Hanesbrands Quarterly |
| 2022-08-11 | 10Q | HBI/Hanesbrands Quarterly |
| 2022-05-06 | 10Q | HBI/Hanesbrands Quarterly |
Receive HBI News And Ratings
See the #1 stock for the next 7 days that we like better than HBI
HBI Financial Statistics
Sales & Book Value
| Annual Sales: | $5.64B |
|---|---|
| Cash Flow: | $88.13M |
| Price / Cash Flow: | 6.95 |
| Annual Sales: | $0.42 |
| Price / Book: | 20.06 |
Profitability
| EPS (TTM): | -0.66000 |
|---|---|
| Net Income (TTM): | $-229.61M |
| Gross Margin: | $1.9B |
| Return on Equity: | -92.19% |
| Return on Assets: | -4.1% |
Hanesbrands Earnings Forecast
Key Hanesbrands Financial Ratios
- The Gross Profit Margin over the past 22 years for HBI is 33.65%.
- The Selling, General & Administrative Expenses for HBI have been equal to 28.52% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is -1,553.39% of Operating Income.
- The Net Earning history of HBI is -0.31% of Total Revenues.
- Per Share Earnings over the last 22 years have been positive in 14 years.
Hanesbrands Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Textiles, Apparel & Luxury Goods |
| Sector: | Consumer Discretionary |
| Current Symbol: | HBI |
| CUSIP: | 410345 |
| Website: | hanes.com |
Debt
| Debt-to-Equity Ratio: | 21.9 |
|---|---|
| Current Ratio: | 1.49 |
| Quick Ratio: | 0.52 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 16 |
HBI Technical Analysis vs Fundamental Analysis
Buy
56
Hanesbrands (HBI)
is a Buy
Is Hanesbrands a Buy or a Sell?
-
Hanesbrands stock is rated a Buy
The current Hanesbrands [HBI] share price is $8.50. The Score for HBI is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.